RT @Yuz6Yusof: Which biomarkers could guide csDMARDs tapering in #RA patients in #remission? Dr Gul reported in a cohort
Tweet Content
Which biomarkers could guide csDMARDs tapering in #RA patients in #remission? Dr Gul reported in a cohort study using a tapering protocol, 35% had relapsed. Risk score for sustained remission comprise IRC<2%, MSK-US PD=0 and RAQoL=<1 (AUC=0.89) #EULAR2021 #OP0182 @RheumNow https://t.co/y1Y6ug7f3w
Show on Archive Page
On
Display in Search Results
On
PDQ
Off